| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3295102 | Gastroenterology | 2009 | 16 Pages |
Abstract
The SNP rs3792323 in MAPKAPK3 associates with the outcome of IFN therapy in patients with HCV genotype 1b. Our functional analyses indicate that MAPKAPK3 inhibits IFN-alfa-induced antiviral activity.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Hironobu Tsukada, Hidenori Ochi, Toshiro Maekawa, Hiromi Abe, Yoshifumi Fujimoto, Masataka Tsuge, Hiroshi Takahashi, Hiromitsu Kumada, Naoyuki Kamatani, Yusuke Nakamura, Kazuaki Chayama,